REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/08/2025
Back to search
Official data from USPTO
CELLDEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
11/09/2025
Trademark type
Word
Nice classes
5
Filing date
08/28/2015
Registration date
11/08/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/03/2023
Last transaction
11/09/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
04/13/2009
First use in commerce
04/13/2009
Drawing code
4
Owner type
03
Owner location
Hampton, NJ
Examiner
TURNER,JASON FITZGERALD
Law office
L80
Current location
TMEG LAW OFFICE 108
Holders and representatives
Holders
CELLDEX THERAPEUTICS, INC.
Representatives
Matthew Hintz, Esq. Lowenstein Sandler Llp
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; Therapeutic vaccines; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for immunotherapy treatment; Antibody drug conjugatespharmaceutical preparations for the treatment of cancerfor the treatment of diseases of the integumentary system and reproductive system; Pharmaceutical preparations derived from monoclonal antibodies for the treatment of cancerfor the treatment of diseases of the respiratory systemcirculatory systemlymphatic systemnervous systemurinary systemdigestive systemintegumentary system and reproductive system; Therapeutic antibodies and immune system modulatorspharmaceutical preparations for the treatment of cancerfor the treatment of diseases of the respiratory systemcirculatory systemlymphatic systemnervous systemurinary systemdigestive systemintegumentary system and reproductive system; Pharmaceutical preparations and substances for use as vaccine adjuvantsgrowth factorsligands and proteins for stem cells in stem cell mobilization; pharmaceutical preparations for the treatment of immune system related diseases and disordersimmune system stimulators and immune system modulators
Publications
History of USPTO decisions and trademark events.
20 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/03/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/03/2023
E815
TEAS SECTION 8 & 15 RECEIVED
05/08/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/08/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/08/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/23/2016
PUBO
PUBLISHED FOR OPPOSITION
08/23/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/15/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/21/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/19/2015
GNRT
NON-FINAL ACTION E-MAILED
12/19/2015
CNRT
NON-FINAL ACTION WRITTEN
12/19/2015
DOCK
ASSIGNED TO EXAMINER
12/11/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/01/2015
NWAP
NEW APPLICATION ENTERED
09/01/2015
Continuous trademark protection
Get notified about every new filing that threatens CELLDEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.